Akebia Therapeutics Inc
AKBA
NASDAQ
Biotechnology
$0.87
USD
0.00 (+0.37%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $240.97M
Volume 2.1M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
MGNX | MacroGenics Inc | $259.34M | - | +2.0% | - | |
RCEL | AVITA Medical Inc | $247.72M | - | +1.0% | - | |
AKBA | Akebia Therapeutics Inc | $240.97M | - | +7.5% | - | |
GLSI | Greenwich Lifesciences Inc | $240.28M | - | - | - | |
TARA | Protara Therapeutics Inc | $233.72M | - | - | - | |
ORGO | Organogenesis Holdings Inc | $230.97M | 84.95 | +12.2% | - | |
ARCT | Arcturus Therapeutics Holdings Inc | $222.41M | - | -76.0% | - | |
CNXU | Conexeu Sciences Inc | $194.53M | - | - | - |
Top Peer by Growth
Organogenesis Holdings Inc
+12.2% YoY Revenue
Lowest P/E Ratio
Organogenesis Holdings Inc
84.95x P/E
Best 1-Year Return
MacroGenics Inc
+145.8% Return